Resolution Therapeutics Announces £63.5 Million Series B …
Oct 3, 2024 · The proceeds from the Series B financing will be used to advance Resolution's lead candidate, RTX001, an autologous, engineered, pro-regenerative macrophage cell therapy …
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · The proceeds from the Series B financing will be used to advance Resolution's lead candidate, RTX001, an autologous, engineered, pro-regenerative macrophage cell therapy …
prnewswire.com
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · Resolution Therapeutics Limited ("Resolution"), a clinical-stage biopharmaceutical company focused on unlocking the regenerative potential of macrophage therapy for the …
yahoo.com
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · Resolution raises £63.5M series B financing from Syncona and appoints Paul Sekhri as Chair of the Board of Directors. ... Edinburgh and London, UK, 3 October 2024 – Resolution …
resolution-tx.com
OFF
Resolution Therapeutics Raises £63.5 Million In Series B Financing …
6 days from now
Oct 3, 2024 · Syncona’s £63.5 million Series B commitment will be used by Resolution to progress the company and advance its lead candidate, RTX001 in end-stage liver disease …
pharmiweb.com
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Mar 10, 2024 · Edinburgh and London, UK, 3 October 2024 – Resolution Therapeutics Limited (“Resolution”), a clinical-stage biopharmaceutical company focused on unlocking the …
synconaltd.com
OFF
Resolution Therapeutics Raises £63.5M In Series B Funding
6 days from now
Oct 3, 2024 · NEW YORK – Resolution Therapeutics on Thursday said it has raised £63.5 million ($83.3 million) in Series B financing led by Syncona. Edinburgh, UK-based Resolution will use …
precisionmedicineonline.com
OFF
Resolution’s £64M Series B To Advance Macrophage Cell Therapy
6 days from now
Oct 3, 2024 · A preview of the next edition of BioWorld, Oct. 3, 2024. Resolution Therapeutics Ltd. is preparing for a phase I/II trial of its autologous engineered macrophage cell therapy, RTX …
bioworld.com
OFF
Syncona Commits £63.5m To Resolution Therapies - Vox Markets
6 days from now
Oct 3, 2024 · Syncona Limited NPV Follow | SYNC announced on Thursday that it has committed £63.5m in series B financing to Resolution Therapeutics, a portfolio company focused on …
voxmarkets.co.uk
OFF
Resolution Therapeutics Raises £63.5M In Series B Financing
6 days from now
Oct 3, 2024 · Resolution Therapeutics, an Edinburgh, Scotland, and London, UK-based clinical-stage biopharmaceutical company, raised £63.5M in Series B funding.. The round was led by …
finsmes.com
OFF
Resolution Therapeutics Scores £63.5 Million In Series B Round
6 days from now
Oct 3, 2024 · UK-based biotech Resolution Therapeutics has raised £63.5 million ($76.8 million) in a series B round led by Syncona to advance its macrophage therapy, RTX001, into clinical …
thepharmaletter.com
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · EDINBURGH, Scotland and LONDON, Oct. 3, 2024 /PRNewswire/ -- Resolution Therapeutics Limited ("Resolution"), a clinical-stage biopharmaceutical company focused on …
epicos.com
OFF
Resolution Therapeutics' Macrophage Therapy Raises $85 Million
6 days from now
Oct 3, 2024 · A week after Vicebio’s $100 million series B round, another U.K.-based biotech makes the headlines. Today, Resolution Therapeutics, a clinical-stage biotech company, …
labiotech.eu
OFF
Resolution Scores $83m To Develop Macrophage Cell Therapies
6 days from now
Oct 3, 2024 · Resolution Therapeutics has raised £63.5m ($83.3m) in a Series B financing round to develop its macrophage cell therapies. The UK-based company plans to use the money to …
pharmaceutical-technology.com
OFF
Edinburgh’s Resolution Therapeutics Raises £63m
6 days from now
Oct 3, 2024 · Edinburgh-based Resolution Therapeutics Limited announced it has raised £63.5 million in Series B financing round led by investment firm Syncona Ltd. Resolution is a clinical …
scottishfinancialreview.com
OFF
Series B - Resolution Therapeutics - 2024-10-03 - Crunchbase
6 days from now
Oct 3, 2024 · Resolution Therapeutics raised $29147914 on 2024-10-03 in Series B ... Organization Name . Resolution Therapeutics . Announced Date Oct 3, 2024; Funding Type …
crunchbase.com
OFF
Resolution Therapeutics Secures $83M To Advance Liver Therapy
6 days from now
Oct 3, 2024 · Resolution Therapeutics was co-founded by Syncona, a UK-based investment trust focused on helping to found, fund and progress healthcare companies, in 2020 after a two …
biopharma-reporter.com
FAQs about Resolution Therapeutics Announces £63.5 Million Series B … Coupon?
How much did resolution raise in Series B financing?
Is resolution a regenerative biopharmaceutical company?
What is resolution Therapeutics?
Will rtx001 go into clinical trials?
Who financed rtx001?
Who is omniabio & resolution Therapeutics?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
